Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. 1990

G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
Department of Anaesthesiology, General Hospital, Malmö, Sweden.

The pharmacokinetics of triglycyl-lysine-vasopressin (TGLVP) were studied in healthy male volunteers after single i.v. injections of 5, 10 and 20 micrograms/kg b. wt. The half-life of distribution and elimination was 8 and 50 min, respectively. The volume of distribution was 0.7 l/kg b.wt. and the plasma clearance 9 ml/kg b.wt./min. These values are different from those for arginine-vasopressin and lysine-vasopressin (LVP) but confirm to some extent earlier results on TGLVP. No dose-dependent changes of the pharmacokinetics of TGLVP were evident. The LVP formation after TGLVP is described in principle using a combination of pharmacokinetic and pharmacodynamic data. Therapeutically the results in this study suggest a 4-hour interval between injections.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008236 Lypressin The porcine antidiuretic hormone (VASOPRESSINS). It is a cyclic nonapeptide that differs from ARG-VASOPRESSIN by one amino acid, containing a LYSINE at residue 8 instead of an ARGININE. Lys-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Lysine Vasopressin,Vasopressin, Lysine,8-Lysine Vasopressin,Diapid,Lys-Vasopressin,Lysyl Vasopressin,Postacton,8 Lysine Vasopressin,Lys Vasopressin,Vasopressin, 8-Lysine,Vasopressin, Lysyl
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077585 Terlipressin An inactive peptide prodrug that is slowly converted in the body to lypressin. It is used to control bleeding of ESOPHAGEAL VARICES and for the treatment of HEPATORENAL SYNDROME. Glipressin,Gly-Gly-Gly-8-Lys-vasopressin,Glycylpressin,Glypressin,N-(alpha)-glycyl-glycyl-glycyl-8-lysine vasopressin,Remestyp,TGLVP,Terlypressin,Triglycyl Lysine Vasopressin,Triglycyl-(8-lysine)vasopressin,Triglycylvasopressin,Vasopressin, tri-Gly-8-Lys-,Gly Gly Gly 8 Lys vasopressin,tri-Gly-8-Lys- Vasopressin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
January 1988, International journal of clinical pharmacology research,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
January 1988, European journal of clinical pharmacology,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
January 1983, International journal of clinical pharmacology research,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
November 1992, Biopharmaceutics & drug disposition,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
December 2014, International journal of clinical pharmacology and therapeutics,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
December 1991, Antimicrobial agents and chemotherapy,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
December 1987, Journal of clinical pharmacology,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
March 2006, Journal of clinical pharmacology,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
December 1998, Journal of clinical pharmacology,
G Nilsson, and P Lindblom, and M Ohlin, and R Berling, and E Vernersson
May 2009, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!